Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Medication-related osteonecrosis: Literature review

Breadcrumb

  • Home
  • Medication-related osteonecrosis: Literature review

Idrovo Campoverde María Coralía *, Bacuilima Ñauta Erika Susana, Pesántez Alvarado Juan Martín and Lafebre Carrasco Milton Fabricio

Faculty of Dentistry, University of Cuenca, Cuenca, Ecuador. 
 
Review Article
World Journal of Advanced Research and Reviews, 2023, 18(02), 705-716
Article DOI: 10.30574/wjarr.2023.18.2.0832
DOI url: https://doi.org/10.30574/wjarr.2023.18.2.0832
 
Received on 29 March 2023; revised on 07 May 2023; accepted on 10 May 2023
 
Objective: The aim of this study is to determine the most likely medication to develop osteonecrosis of the jaw, the route of administration, dose and treatment time that carry the greatest risk, and to establish appropriate prevention strategies in order to provide new knowledge for the management of patients who are at risk or that are developing medication-related osteonecrosis of the jaw. 
Materials and methods: Literature review of the last 5 years in the databases PubMed, ScienceDirect and Springer Link, using the following terms: osteonecrosis in dentistry, osteonecrosis of the jaws and drug related osteonecrosis of the jaws.
Results: A total of 20,662 articles were obtained from the three digital databases; after applying exclusion and inclusion criteria, 51 articles were selected for the literature review.
Conclusion: MRONJ is a rare but potentially serious condition associated with prolonged use of antiresorptive and antiangiogenic agents. However, because of the heterogeneity of evidence, the administration route of greatest risk has not been accurately determined.
 
Antiangiogenic agents; Antiresorptive; Bisphosphonates; Denosumab; Drug-related osteonecrosis; Osteonecrosis of the jaws; Intravenous route; oral route
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2023-0832.pdf

Preview Article PDF

Idrovo Campoverde María Coralía, Bacuilima Ñauta Erika Susana, Pesántez Alvarado Juan Martín and Lafebre Carrasco Milton Fabricio. Medication-related osteonecrosis: Literature review. World Journal of Advanced Research and Reviews, 2023, 18(2), 705-716 . Article DOI: https://doi.org/10.30574/wjarr.2023.18.2.0832

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution